Literature DB >> 24005899

Neuropeptide downregulation in sepsis.

Fabiano Pinheiro da Silva1, Marcel Cerqueira César Machado, Paulo Clemente Sallet, Fernando Godinho Zampieri, Alessandra Carvalho Goulart, Francisco Torggler Filho, Hermes Vieira Barbeiro, Irineu Tadeu Velasco, Luiz Monteiro da Cruz Neto, Heraldo Possolo de Souza.   

Abstract

Neuropeptides are an extremely conserved arm of neurobiology. Despite their effects as neurohormones and neurotransmitters, a multitude of other effects have been described, putting in evidence their importance as regulators of immune responses, such as chemotaxis, oxidative burst, pro-inflammatory signaling, and many others. The effects of neuropeptides in the pathophysiology of sepsis, however, remain poorly investigated. A prospective cohort study to investigate the effects of neuropeptides in sepsis was carried out. Here, we describe that neuropeptides are downregulated during septic shock. We propose that it may be a protective mechanism of the host to avoid further inflammatory injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24005899     DOI: 10.1007/s10753-013-9722-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  14 in total

1.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

Review 2.  Sepsis-associated delirium.

Authors:  Marion Ebersoldt; Tarek Sharshar; Djillali Annane
Journal:  Intensive Care Med       Date:  2007-04-05       Impact factor: 17.440

3.  Role of central NO-cGMP pathway in vasopressin and oxytocin gene expression during sepsis.

Authors:  Gabriela Ravanelli Oliveira-Pelegrin; Fábio Alves Aguila; Paulo José Basso; Maria José Alves Rocha
Journal:  Peptides       Date:  2010-07-16       Impact factor: 3.750

4.  Cathelicidin LL-37 bloodstream surveillance is down regulated during septic shock.

Authors:  Denise Frediani Barbeiro; Hermes Vieira Barbeiro; Fernando Godinho Zampieri; Marcel Cerqueira César Machado; Francisco Torggler Filho; Débora Maria Gomes Cunha; Alessandra Carvalho Goulart; Irineu Tadeu Velasco; Luiz Monteiro da Cruz Neto; Heraldo Possolo de Souza; Fabiano Pinheiro da Silva
Journal:  Microbes Infect       Date:  2013-01-14       Impact factor: 2.700

Review 5.  Melatonin in bacterial and viral infections with focus on sepsis: a review.

Authors:  Venkataramanujam Srinivasan; Mahaneem Mohamed; Hisanori Kato
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2012-01

6.  AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality.

Authors:  K Doi; X Hu; P S T Yuen; A Leelahavanichkul; H Yasuda; S M Kim; J Schnermann; T E N Jonassen; J Frøkiaer; S Nielsen; R A Star
Journal:  Kidney Int       Date:  2008-03-19       Impact factor: 10.612

Review 7.  Sepsis-associated encephalopathy.

Authors:  Teneille E Gofton; G Bryan Young
Journal:  Nat Rev Neurol       Date:  2012-09-18       Impact factor: 42.937

Review 8.  Sepsis-induced brain dysfunction.

Authors:  Nicolas Adam; Stanislas Kandelman; Jean Mantz; Fabrice Chrétien; Tarek Sharshar
Journal:  Expert Rev Anti Infect Ther       Date:  2013-02       Impact factor: 5.091

9.  Hydrogen sulfide and neurogenic inflammation in polymicrobial sepsis: involvement of substance P and ERK-NF-κB signaling.

Authors:  Seah-Fang Ang; Shabbir M Moochhala; Paul A MacAry; Madhav Bhatia
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

Review 10.  Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential.

Authors:  Daria Augustyniak; Judyta Nowak; Fionnuala T Lundy
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

View more
  2 in total

1.  Immune stimulation by exogenous melatonin during experimental endotoxemia.

Authors:  Katharina Effenberger-Neidnicht; Lisa Brencher; Martina Broecker-Preuss; Tim Hamburger; Frank Petrat; Herbert de Groot
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

2.  Interleukin-1 Receptor Antagonist Decreases Hypothalamic Oxidative Stress During Experimental Sepsis.

Authors:  Fazal Wahab; Nilton N Santos-Junior; Rodrigo Pereira de Almeida Rodrigues; Luis Henrique A Costa; Carlos Henrique R Catalão; Maria Jose A Rocha
Journal:  Mol Neurobiol       Date:  2015-07-17       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.